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High altitudes and the associated hypoxia pose 
physiological challenge to ensure organism survival. 
The term “acclimatization” is used to describe 
phenotypic alterations as a response to exposure 
to high altitudes. Little is known about functional 
adaptations to chronic hypobaric exposure of 
unconditioned populations (1). High altitude living 
produces physiological changes, including skeletal 
muscle (SM) characteristic and functionality, as 
consequences of adaptation to chronic hypobaric-
hypoxemic environment (HHE). The scientific 
community agree that severe altitude exposure 
determines a loss of body weight (5%-10%) (2), 
while contrasting results have been reported about 
the effect on loss of SM mass (3) and changes in 
fiber cross-sectional areas (4). Physical activity may 
counteract the muscle loss. Thus, several parameters 
such as total time of exposure, the degree of hypoxia, 
and physical activity levels may markedly influence 
the adaptation of SM to hypoxia. In response to high 
altitude exposure, other compensatory changes also 
occur in the muscle tissues (5). Hypoxia stimulates 
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alphanumerical code (C as climber followed by a number). 
Health evaluations indicated that none of these subjects 
suffered from cardiovascular, respiratory, metabolic, or 
SM diseases. The health conditions of climbers were 
assessed at the time of each muscle biopsy. Written 
consent was obtained from each participant, and the study 
was designed in accordance with the recommendations of 
the Declaration of Helsinki and approved by the Ethics 
Committee of the Gabriele d’Annunzio University of 
Chieti-Pescara, Italy (protocol no. 1634/08 COET). 
The climbers took part in the INTERAMNIA 8000 
- MANASLU 2008 expedition that started from Rome 
(at sea level) on 8 September, 2008, and ended again 
in Rome on 20 October, 2008. The subjects had not 
experienced high-altitude conditions within a period of 
at least 6 months prior to this expedition. After landing in 
Kathmandu, Nepal (~1,350 m a.s.l.) on 9 September, 2008, 
the climbers began the ascent phase on 11 September, 
2008, to reach the Manaslu Base Camp (5,000 m a.s.l.) 
on 21 September, 2008. During this 10-day period, the 
climbers covered approximately 25 km/day and averaged 
about 7 h of trekking each day. The climbers remained 
at the base camp for 21 days, during which time they 
showed very few symptoms of acute mountain sickness, 
which decreased after a few days; no climber needed 
any medication. Throughout the expedition, a balanced 
food intake and ad-libitum fluid ingestion was allowed. 
When the meteorological conditions were favorable, the 
climbers reached Camp 1 (5,900 m a.s.l.) and Camp 2 
(6,400 m a.s.l.), covering approximately 8-10 km/day, 
an average of 6 h of trekking per day. During the period 
at the base camp, the climbers attended to their personal 
needs, re-arranged their tents, and maintained the camp. 
Nepalese Sherpa packers and base-camp personnel 
supported the expedition; however, no data were collected 
from these Nepalese citizens. On 19 October, 2008, the 
subjects reached Kathmandu, and left on their return flight 
the following day. After landing in Rome on 20 October, 
2008, the climbers were transferred to Chieti (Italy) for 
health evaluation and muscle biopsy. 
Muscle needle biopsy
Muscle biopsies were taken before the expedition, 
after their return from Kathmandu and for C5 2 years 
after the expedition using a tiny percutaneous needle 
biopsy as described in Pietrangelo et al, 2009 (11). One 
sample was collected in HAM’s Nutrient Mixture F10 
(#ECB7503SL, Euroclone, Milan, Italy) supplemented 
with 1% gentamicin (#ECM0011B, Euroclone) and stored 
1 day at 4°C, until used to isolate SCs. Another sample 
of about 10 mg was collected in RNA Later (#AM7020, 
Ambion, Milan, Italy), and stored at -80°C until used to 
perform transcriptional profile analysis. Another sample 
vascular endothelial growth factor (VEGF) 
production via hypoxia-inducible factor-1α (HIF1) 
promoting angiogenesis and blood flow and supplying 
more oxygen to the tissues (6); mitochondria number 
and myoglobin increase facilitating movement of 
O
2
 into the tissues and its utilization (5). The tissue 
content of cytochrome oxidase also increases (7). 
Environmental stimuli induce muscle adaptation 
and, in turn, muscle regeneration. In adults, muscle 
regeneration depends on satellite cell (SC) activation. 
SCs are undifferentiated quiescent mononucleated 
cells found in muscle with properties of stem cells 
residing close to the basal lamina. In response 
to a stimulus, SCs are activated to proliferate as 
myoblasts that migrate to the targeted region of 
a muscle fiber to differentiate and fuse to form 
myotubes via a similar process to that of myogenesis. 
Myogenesis is highly regulated by muscle-specific 
transcriptional regulators. SCs express characteristic 
proteins but are heterogeneous for Pax7 protein. 
Upon activation, SCs proliferate and up-regulate 
MyoD. Depending on the expression levels of 
MyoD, Pax7 and myogenin, proliferating myoblasts 
can be committed to differentiation or remain in a 
proliferative state or exit the cell cycle to form a 
new SC pool (8). In a study of climbers exposed to 
high altitude, an increased volume density of SCs 
and lipofuscin levels were shown after exposure to 
high altitudes, suggesting a failed activation of SCs 
and uncertain results in term of muscle regeneration 
(9). To date, very few studies have investigated the 
effects of hypoxia in human SCs ex vivo. It has been 
demonstrated that molecular tools are useful to study 
muscle plasticity mechanisms and also to distinguish 
the molecular signature of an expressional adaptation 
when hypoxic stress is added to an exercise protocol 
in climbers (10). In the present study, we investigated 
the adaptation mechanisms in the Vastus lateralis 
(VL) SM induced by physical activity while under 
hypoxia at high altitudes. Using VL muscle needle 
biopsies (pre- and post-expedition), cellular features 
and gene expression profiles were analyzed.
MATERIALS AND METHODS
Subjects and expedition
Six healthy, male, non-smoking climbers with 
an average age of 42±6 (± Standard Error, SE) were 
enrolled in the study. Each climber was identified with an 
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was collected in ice cold skinning solution with 50% (v/v) 
glycerol (12) and stored at –20°C until used to perform the 
count of myonuclei and SCs by immunofluorescence.
Cell culture
The VL muscle needle biopsies were processed 
according to the procedures of Fulle et al. (2005). All of the 
muscle biopsies obtained from all of the climbers before 
and after the expedition were used to isolate SCs. The first 
mononucleated cells migrated from the explants at 7-13 
days from the beginning of the culture (independent of 
donor age). Cell cultures were considered senescent 
when they did not reach one population doubling level 
(PDL) after three weeks of re-feeding (13). To induce the 
differentiation of mononucleated cells into multinucleated 
myotubes, myoblasts were plated at a confluence of 10,000 
cells/cm2 and maintained for two days in growth medium. 
At 2-3 days after plating, the medium was replaced 
with differentiation medium: DMEM high glucose 
(#ECB7501L, Euroclone) supplemented with 5% horse 
serum (#ECS0091L, Euroclone), 50 μg/ml gentamicin 
(#ECM0011B, Euroclone), 10 μg/ml insulin (#I-0516, 
SIGMA Chemical Co.; St. Louis, MO, USA) and 100 
μg/ml apo-transferrin (#T-2036, Sigma). We followed 
the differentiation process until day 7. The efficiency of 
differentiation was determined by counting the number 
of nuclei in seven-day-differentiated myotubes as a 
percentage of the total number of nuclei. The ratio of the 
two values was defined as the fusion index. At least 1,500-
2,000 nuclei were counted in 25-30 different randomly 
selected fields.
Immunocytochemistry
The myogenic purity of SC populations was calculated 
using desmin as a marker. Desmin expression was 
determined using the D33 antibody (Dako, dilution 1/50) 
and immunostaining with the biotin streptavidin complex 
method (Dako), as described by Decary et al. (13).
Counting of myonuclei and SCs by immunofluorescence
Single muscle fibers were manually dissected 
from the biopsy samples collected from each subject 
before and after expedition and analyzed by immune 
fluorescence techniques to determine the nuclear domain 
and to count the SCs. Single fibers were fixed with 4% 
paraformaldehyde in PBS for 20 min at room temperature. 
The fibers were permeabilized with 0.1% Triton X-100 in 
PBS at RT, and then incubated in 10% normal goat serum 
for at least 30 min to block non-specific antibody binding. 
Mouse anti Pax-7 (R&D System, Milan, Italy) monoclonal 
antibody (1:400) was applied at RT o/n at 4°C in PBS. 
After 3 washes (10 min each), fluorescent secondary 
Alexa-568 anti-mouse, (Molecular Probes) antibody was 
incubated for 2 h at room temperature. For visualization 
of nuclei, single fibers were stained with Hoestch (25 
μg/ml; SIGMA) for 10 min. The fibers were viewed 
with a confocal microscope (VICO; Nikon) and number 
of nuclei and of Pax-positive nuclei were determined 
in segments of fibers where length and diameters were 
measured and volume was calculated. The reciprocal of 
the nuclear domain was determined as number of nuclei in 
a given fiber volume, while the SC density was expressed 
as the percentage of Pax7 positive nuclei.
Statistical analysis
Data were expressed as means ±SE. Statistical 
significance was set at p<0.05 and was calculated using 
the unpaired Student’s t-test, with Welch’s correction. 
Prism5 GraphPad software (Abacus Concepts GraphPad 
Software, San Diego, CA, USA) was employed for 
statistical analyses.
Gene profiling of muscle biopsies
The transcriptional profile analysis was performed 
as described by Mancinelli et al. (2011) using high 
quality RNA obtained from 5 of these 6 subjects for the 
microarray experiments (14). The statistical analysis was 
performed using values corresponding to the log
2
 ratios of 
the normalized intensities (e.g., log
2
 I
post-expedition
/ I
pre-expedition
), 
where positive numbers corresponded to RNA over-
expressed in muscle after the expedition. Differentially 
expressed genes were identified using the significant 
analysis of microarrays (SAM) permutation test procedure 
(STANFORD software, http://www-stat.stanford.edu/
�tibs/SAM), which defines genes with a computed 
score greater than the threshold value as significant. 
The false discovery rate (FDR) associated with a given 
threshold was also calculated from the permutation data. 
We assessed the genes obtained from the SAM analysis 
according to their Δ and FDR as reported in Table I. The 
total number of common differentially expressed genes 
(common to at least two of the subjects) was 19, although 
we did not include genes for which a function was not 
known. Several differentially expressed (up-regulated and 
down-regulated) genes coding for proteins implicated in 
different pathways are shown in Table II.
RESULTS
Muscle regeneration depends on SCs. Reduced 
numbers and/or decreased myogenicity of these cells 
can impede correct muscle maintenance and 
contribute to a decline in muscle mass and repair 
capacity. To determine whether muscle adaptations 
to an extreme environment can alter the SC 
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basis in a reduced number of SCs, myonuclei and 
SCs were counted in muscle fibers before and after 
the expedition. After the expedition, the total density 
of nuclei was greater than before the expedition: the 
mean ± SE was 140.5±7.4/106μm3 (N=15 fibers from 
6 climbers), while the mean before expedition was 
122.5±6.2/106μm3 (N=31 fibers from 6 climbers) 
indicating a reduction of nuclear domain. The 
percentage of Pax7 positive nuclei on 100 nuclei was 
significantly decreased (p<0.05) from 1.336±0.1877 
(N=10) before the expedition and 0.5279±0.2061 
(N=7) after the expedition (Fig. 3). Furthermore, we 
analyzed the muscle adaptations to HHE and 
exercise performed under extreme conditions using 
the transcriptional profile analysis of the VL muscle, 
comparing the gene expression profile after the 
expedition with that from before the expedition, 
from the same subjects (Table II). We assessed genes 
obtained from SAM analysis (see Materials and 
Methods section) according to Δ and false discovery 
rates reported in Table I. The total number of 
differentially expressed genes was on the average 
140 per subject and we did not insert genes the 
function of which is unknown. Several differentially 
expressed (up- and down-regulated) genes coding 
for proteins implicated in diverse pathways were 
observed and we carefully analyzed and described 
those that we found to be differentially regulated in 
at least two subjects, as listed in Tables II, according 
to their common functions. It was found that exercise 
itself can induce dysregulation of genes involved in 
myogenesis. In the present study there was up-
regulation of myogenic factor 6 (herculin), the gene 
that codes for MRF4, which together with the 
myogenic basic helix-loop-helix family of 
population, and thus their regenerative capacity, we 
isolated and characterized these cells. Consistent 
with the findings of Renault et al. (2000), the in vitro 
proliferative life span of myoblasts was limited and 
was related to donor age (15). In adult age, once the 
period of muscle growth ceases, the proliferative 
capacity of SCs tends to plateau, as reported Fig. 1. 
Cell cultures isolated from the VL biopsies of the 
climbers before the expedition were characterized 
according to their myogenic purity (% of desmin/+ve 
cells) and fusion index (%). The number of myogenic 
cells was as expected, according to our previous data 
(16). Moreover, their ability to fuse with each other 
into functional multinucleated cells (calculated as 
the fusion index in seven-day-differentiated 
myotubes) did not change across the cell cultures 
from these subjects (Table III). After exposure of the 
subjects to the HHE, in all except one of the samples, 
the SCs derived from the muscle biopsies did not 
migrate out of the explants. In fact, after the 
expedition, only one muscle sample obtained from 
the climber C6 did provide SCs  (Table III, last row). 
However, the C6 POST SC myogenicity percentage 
was decreased by 40%, the fusion index by 50% and 
the positive desmin unfused cells by 95% (Table III). 
The proliferative capability of SC culture (C6) 
obtained after the expedition was compared to that 
obtained from the same climber before the expedition 
(Fig. 2). The graph shows that after the expedition 
the SCs slow down their proliferation rate despite 
them reaching the same number of division (PDL). 
Noteworthy, 2 years after the expedition, SC culture 
was obtained by C5 SM biopsy showing a 51.5% of 
miogenicity (Table III, C5 follow up, FU). To test 
whether the reduced myogenic activity could find a 
21 
Fig. 3. Total nuclear density and percentage of SCs in single muscle fibers before and 
after the expedition. Panel A) Number of nuclei in a fixed volume (106 µm3); panel B) 
Percentage of Pax7 positive nuclei; white columns, before expedition, black columns, 
after expedition. The data are expressed as means and standard errors, * indicates the 
statistically significant decrease in Pax7 positive nuclei after expedition (p<0.05). 
Table I. Statistical parameters used for the analysis of significance of the microarray 
permutation test procedures. 
Statistical 
parameter 
Subjects 
 C1 C3 C4 C5 C6 
 0.04 0.54 0.12 0.19 0.16 
False discovery 
rate (median)  
0.55 0.052 0.14 0.04 0.20 
Known genes (n) 130 139 135 147 152 
Each climber was identified by an alphanumerical code (C as climber followed by a number). 
Table I. Statistical parameters used for the analysis of significance of the microarray permutation test procedures.
Each climber was identified by an alphanumerical code (C as climber followed by a number).
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22 
Table II. Descriptions of differentially expressed genes (common at least to 2 
climbers). 
NCBI 
gene 
no. 
Official 
symbol 
Description Mean log2 Ipost/Ipre* 
   C1 C3 C4 C5 C6 
Oxidative metabolism 
549 AUH AU RNA binding 
protein/enoyl-
Coenzyme A hydratase 
0.90     0.58 
522 ATP5J ATP synthase, H+
transporting, 
mitochondrial F0 
complex, subunit F6 
0.68   0.78    
5507 PPP1R3C Protein phosphatase 1, 
regulatory (inhibitor) 
subunit 3C 
-0.55    -0.83   
3030 HADHA Hydroxyacyl-
Coenzyme A 
dehydrogenase/3-
ketoacyl-Coenzyme A 
thiolase/enoyl-
Coenzyme A hydratase 
   0.97  0.56  
28965 SLC27A6 Fatty-acid-Coenzyme A 
ligase, long-chain 2 
   0.86  0.56  
2593 GAMT Guanidinoacetate N-
methyltransferase 
   -1.91  -0.58  
36 ACADSB Acyl-Coenzyme A 
dehydrogenase, 
short/branched chain 
 0.62    0.99  
Protein balance 
4738 NEDD8 Neural precursor cell 
expressed, 
developmentally down-
regulated 8 
  -1.12  -1.21   
55585 NICE5 NICE-5 protein -0.93    -0.96   
Sarcomeric protein 
9172 MYOM2 Myomesin (M-protein) 
2 (165kD) 
  1.15   0.65  
5339 PLEC1 Plectin 1, intermediate 
filament binding 
protein, 500kD 
  0.92   0.82  
7140 TNNT3 Troponin T3, skeletal, 
fast 
  -0.77   -0.89  
23336 SYNM Desmuslin    1.03  0.45  
8048 CSRP3 Cysteine and glycine-
rich protein 3 (cardiac 
LIM protein) 
0.84   0.95    
23 
Cell cycle 
5774 PTPN3 Protein tyrosine 
phosphatase, non-
receptor type 3 
  1.16   1.23  
5515 PPP2CA Protein phosphatase 2 
(formerly 2A), catalytic 
subunit, alpha isoform 
  0.85  1.02   
9020 MAP3K14 Mitogen-activated 
protein kinase kinase 
kinase 14 
  -0.94  -1.03   
Myogenesis 
7123 CLEC3B Tetranectin 
(plasminogen binding 
protein) 
-0.82   -0.83    
4618 MRF4 Myogenic factor 6 
(herculin) 
  0.93  1.22  
The first column specifies NCBI gene number, the second column, the official symbol, the third column 
the description of the different genes up- or down-regulated in the VL muscle, when post- and pre-
expedition expression levels were compared. The other columns report changes in expression levels of 
genes for each climber analyzed as means of the log base-2 of the ratios (log2 Ipost-expedition/Ipre-expedition). 
* Up-regulated genes have positive values, and down-regulated genes have negative values. 
Table II. Descriptions of differentially expressed genes (common at least to 2 climbers).
The first column specifies NCBI gene number, the second column, the official symbol, the third column the description 
of the different genes up- or down-r gulat d in the VL muscle, when post- and r -expedition expression levels were 
compared. The other columns report changes in expression levels of genes for each climber analyzed as means of the log 
base-2 of the ratios (log
2
 I
post-expedition
/I
pre-expedition
).
* Up-regulated genes have positive values, and down-regulated genes have negative values.
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inactivation of ribosomal protein S6 kinase, 70-kD, 
polypeptide 1 (p70 kinase 1). Inactivated p70 kinase 
1 fails to oppress the activity of glycogen synthase 
kinase 3 beta (GSK3β). In this case, GSK3β 
phosphorylates cyclin D, making it accessible to 
subsequent ubiquitination and proteosomal 
degradation (18). In addition, there was down-
regulation of mitogen-activated protein kinase 
kinase kinase 14 (MAP3K14) gene, which codes for 
a Ser/Thr protein kinase. This kinase binds to 
TRAF2 and stimulates NF-kappaB activity (19). 
Other genes found dysregulated are involved in the 
oxidative metabolism pathway. Genes dysregulated 
in the VL muscle samples after the expedition 
showed a shift towards oxidative metabolism, in 
respect to the expression before the expedition. 
Indeed, we found up-regulation of the AU RNA 
binding protein/ enoyl-coenzyme A hydratase 
(AUH), a gene that codes for a mitochondrial protein 
that binds to the AU-rich element, a common 
element found in the 3’-UTR of rapidly decaying 
mRNA, such as for c-fos, c-myc and granulocyte/
macrophage colony stimulating factor. These AU-
transcription factors (MyoD, Myf5, myogenin), can 
activate the muscle differentiation program (8). 
Tetranectin (plasminogen binding protein) 
(CLEC3B) was down-regulated after exposure to the 
HHE, and it codes for a protein marker for 
myogenesis during embryonic development, muscle 
regeneration, and muscle cell differentiation in vitro 
. The down-regulation of  tetranectin could be related 
to the fibrinolytic state after exercise training, as 
recently demonstrated (17). Another pathway that is 
significantly modified when SM is exposed to HHE 
and exercise is performed involved the regulation of 
the cell cycle. The protein encoded by the protein 
tyrosine phosphatase, non-receptor type 3 (PTPN3) 
gene is a signaling molecule that regulates a variety 
of cellular processes, including cell growth and 
differentiation, and the mitotic cycle. This gene was 
up-regulated, together with protein phosphatase 2 
(formerly 2A), catalytic subunit, alpha isoform 
(PPP2CA), which codes for the phosphatase 2A 
catalytic subunit, one of the four major Ser/Thr 
phosphatases implicated in negative control of cell 
growth and division, through dephosphorylation and 
24 
Table III. Myogenicity, fusion index and desmin-+ve non-fused cell characteristics of 
the cell cultures isolated from the VL biopsies of the climbers before the expedition, 
including the single sample obtained after the expedition (C6).  
Cell Culture Myogenicity % 
(desmin+ve) 
Fusion Index  
(%) 
Desmin+ve Unfused 
(%) 
C1 PRE 62.5 44.0 33.4 
  POST n.d. n.d. n.d. 
C2 PRE 58.2 69.5 22.6 
 POST n.d. n.d. n.d. 
C3 PRE 51.7 67.6 21.0 
 POST n.d. n.d. n.d. 
C4 PRE 40.4 57.6 12.1 
  POST n.d. n.d. n.d. 
C5 PRE 61.3 68.9 10.8 
 POST n.d. n.d. n.d. 
 FU 51.5 n.d. n.d. 
C6 PRE 64.8 58.6 12.5 
 POST 39.3 29.8 0.6 
Two years after the expedition cell culture was obtained by C5 biopsy (C5 follo- up, 
FU). Each climber was identified with an alphanumerical code (C as climber followed 
by a number).In all except one of the post samples, the SCs derived from the muscle 
biopsies did not migrate out of the explants; biopsy that was obtained from the only one 
climber (C6) did provide SCs; biopsy that was obtained from the only one climber (C5 
FU) did provide SCs 2 years after the expedition. 
n.d. means not detected. 
Table III. Myogenicity, fusion index and desmin-+ve non-fused cell characteristics of the cell cultures isolated from the VL 
biopsies of the climbers before the expedition, including the single sample obtained after the expedition (C6). 
Two years after the expedition cell culture was obtained by C5 biopsy (C5 follo- up, FU). Each climber was identified 
with an alphanumerical code (C as climber followed by a number).In all except one of the post samples, the SCs derived 
from the muscle biopsies did not migrate out of the explant ; biopsy that was obtained from the only one climber (C6) did 
provide SCs; biopsy that was obt ined from the only one clim er (C5 FU) did pr vide SCs 2 years after the expedition.
n.d. means not detected.
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rich elements are involved in directing the RNA to 
rapid degradation and de-adenylation. AUH is also 
homologous to enol-CoA hydratase, an enzyme that 
is involved in fatty-acid degradation and that has 
been shown to have intrinsic hydratase enzymatic 
activity. AUH is thus a bifunctional chimera, between 
RNA binding and metabolic enzyme activity (20). 
ATP synthase, H+ transporting, mitochondrial F0 
complex, subunit F6 (ATP5J), which codes for the 
mitochondrial ATP synthase that catalyses ATP 
synthesis, was up-regulated. Moreover, the up-
regulated hydroxyacyl-coenzyme A dehydrogenase/ 
3-ketoacyl-coenzyme A thiolase/ enoyl-coenzyme A 
hydratase (HADHA) gene codes for the alpha subunit 
of the mitochondrial trifunctional protein, which 
catalyses the last three steps of mitochondrial beta-
oxidation of long-chain fatty acids. Linked to this 
last gene, the fatty-acid-coenzyme A ligase, long-
chain 2 (SLC27A6) gene codes for a member of the 
fatty-acid transport protein family, and it was also 
up-regulated. The fatty-acid transport protein family 
is involved in the uptake of long-chain fatty acids 
and its members show unique expression patterns 
(21). Acyl-coenzyme A dehydrogenase, short/
branched chain (ACADSB) was found to be up-
regulated after the expedition, as compared to before. 
This gene codes for an enzyme that catalyses 
Fig. 1. Proliferative life span of human SCs. Cell 
populations isolated from VL biopsies of the climbers 
before the expedition were serially passaged and cultured 
until their cell division ceased. At each passage, the 
population doubling level was calculated by counting 
cell numbers.
Fig. 2. The two curves represent the life spans of the SC 
cultures isolated from VL biopsies obtained from climber 
C6 before (PRE) and after the expedition (POST).
Fig. 3. Total nuclear density and percentage of SCs in 
single muscle fibers before and after the expedition. Panel 
A) Number of nuclei in a fixed volume (106 µm3); panel B) 
Percentage of Pax7 positive nuclei; white columns, before 
expedition, black columns, after expedition. The data are 
expressed as means and standard errors, * indicates the 
statistically significant decrease in Pax7 positive nuclei 
after expedition (p<0.05).
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SCs showing significantly decreased myogenicity 
percentage and fusion index of 40% and 50%, 
respectively, compared to cell cultures obtained 
from the same subject before the expedition. 
Furthermore, the failed coming-out of SCs from 
explants after the expedition could be related 
to the lower number of Pax-7 positive cells that 
we found. The reduction in the density of these 
myogenic precursor cells after expedition to about 
30% of the value determined before expedition is 
therefore consistent with the decreased myogenic 
response. The delayed activation of SCs exposed to 
HHE when put in culture could be explained by two 
possible mechanisms: (1) lipofuscin accumulation 
in SCs (9) preventing their differentiation into 
functional cells, with the consequent damage and 
loss of maintenance of the stem cell pool (26); (2) 
the deregulation of genes involved in negative cell-
cycle regulation. However, the SCs pool was only 
temporarily exhausted as demonstrated by collection 
of SC culture from a biopsy collected 2 years after 
the expedition. In several studies on mountaineering 
muscle atrophy with reduction of cross-sectional 
area and muscle mass has often been reported. 
Ubiquitin-proteasome system usually mediates the 
atrophic process and also HIF-α oxygen-dependent 
ubiquitination. Conversely, under hypoxia, HIF-
α escape this mechanism activating numerous 
hypoxia-inducible genes (27). 
The down-regulation found in our study 
of genes involved in the proteolytic pathway 
suggests the activation of HIF-mediated adaptation 
mechanisms to hypoxia. In general, genes that code 
for sarcomere-specific proteins were up-regulated. 
Furthermore, this result is in agreement with other 
data obtained from same climbers, demonstrating 
for the first time a significant increase in slow type 
fibers after the expedition (28). The up-regulation of 
sarcomeric genes confirms data already published 
demonstrating that the myofibrillar protein synthesis 
rate is markedly elevated after high altitude hypoxia 
(29). The down-regulation of the proteolytic pathway 
together with up-regulation of sarcomeric protein 
suggest an anabolic positive balance probably due 
to the exercise at high altitude. In fact, even though 
a reduction in anthropometric parameters was found, 
the development of force did not change, while the 
cross-sectional area increased with the absence of 
dehydrogenation of acyl-CoA derivatives in the 
metabolism of fatty acids and branch-chained amino 
acids (22). In contrast, protein phosphatase 1, 
regulatory (inhibitor) subunit 3C (PPP1R3C), which 
codes for a protein involved in glycolytic metabolism, 
and guanidinoacetate N-methyltransferase (GAMT), 
which codes for a methyltransferase that converts 
guanidoacetate to creatine (23), were found to be 
down-regulated. Two genes linked to ubiquitin-
dependent protein degradation processes were 
down-regulated after the expedition, compared with 
before: neural precursor cell expressed, 
developmentally down-regulated 8 (NEDD8), which 
codes for a protein that activates ubiquitination 
through an increase in the efficiency of polyubiquitin 
chain assembly that is modulated by its covalent 
conjugation to cullin molecules (24); and NICE-5 
protein, which codes for a protein member of the E2 
ubiquitin-conjugating enzyme family. In agreement 
with the down-regulation of protein-degradation 
processes, genes that code for sarcomere-specific 
proteins were also up-regulated. Myomesin (M-
protein) 2 (MYOM2) codes for titin, which 
interconnects the M bands and Z discs. Plectin 1, 
intermediate filament binding protein (PLEC1) 
codes for the plectin protein that can interlink 
different elements of the cytoskeleton in SM. The 
protein encoded by desmuslin (SYNM) is an 
intermediate filament family member that has been 
shown to form a link between desmin and the 
extracellular matrix, which provides important 
structural support in muscle. Cysteine and glycine-
rich protein 3 (cardiac LIM protein) (CSRP3) was 
also up-regulated. The protein encoded by this gene 
interacts with cytoskeletal actin-regulating F-actin 
depolymerization (25), whereby deregulation of this 
interaction leads to sarcomere dysfunction and 
disease. The gene troponin T3, skeletal, fast (TNNT3) 
codes for the skeletal troponin T protein, and this 
was also down-regulated.
DISCUSSION
In the present study, we characterized SC 
cultures obtained from the VL needle biopsies of 
these climbers before and after the expedition. 
Noteworthy, after the expedition, only one (C6) out 
of six VL needle biopsies of the climbers provided 
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atrophy following the expedition (28). The physical 
activity carried out by the climbers consisted of 
trekking that took them down to return to sea level 
providing lengthening contractions (eccentric 
muscle contractions). As previous studies have 
reported, exercise induces changes in expression of 
MRFs and IGF-1, at both the mRNA and protein 
levels. In agreement with previous reports, we found 
up-regulated genes involved in the process of muscle 
building. After high altitude expedition the overall 
picture that emerges shows a lack of action by the 
SCs to regeneration and/or muscle growth. In spite 
of this, our results show an increase of total density 
of fiber myonuclei. This result is also supported by 
data deriving from the same climbers (28) showing 
an increase in fiber cross-sectional area. It has been 
shown that hypertrophy can occur as a result of 
physical activity with enhanced transcriptional and 
translational activities (30) that we find increased 
based on deregulation of the protein balance and 
up-regulation of sarcomeric protein pathways. In this 
case, the role of SCs could be explained as described 
above. The participation of other myogenic cells in 
fusion events that induce changes in cross-sectional 
area and muscle dimension is also to be considered 
(31). With SM activity, the mitochondria have a 
pivotal role in ATP production, a pathway that 
requires oxygen. When cells are exposed to hypoxia, 
adaptive mechanisms mediated by AMPK and HIF1 
and metabolic changes take place (32). Furthermore, 
Hoppeler (2001) reported a shift towards oxidative 
metabolism as a compensation mechanism during 
training under hypoxia (33). The larger oxidative 
capacity also necessitates adaptations in oxygen 
transfer system, normally detectable in subjects 
exposed to HHE. This effect was also induced by 
the eccentric contractions that occurred during the 
descending phase of the expedition. Indeed, it is 
well documented how training can induce fiber type 
transitions towards a slow-oxidative phenotype (34). 
The shift towards a slow-oxidative phenotype, in 
agreement with data obtained from Doria et al. (28), 
is supported by up-regulation of genes involved in 
oxidative metabolism. Furthermore, this shift is 
supported by the down-regulation of genes involved 
in glycolytic metabolism, regulated by HIF1 under 
hypoxia, revealing a novel metabolic adaptation 
of cells to hypoxia (35). Therefore, overall, the 
up-regulation and down-regulation of these genes 
lead us to hypothesize a metabolic shift to oxidative 
processes. Taken together, the results we obtained 
suggest that the exposure to HHE accompanied 
by physical activity lead to remodelling of SM in 
which loss of muscle mass (with an increase in 
cross sectional area) does not appear due to the 
participation of SCs. A key role seems instead be 
played by increasing sarcomeric protein synthesis 
and the decrease in proteolytic degradation with a 
positive muscle balance, or an absence of atrophy 
and muscle loss. These data were supported by the 
initial contribution of SCs to fuse with fibers in 
response to the stimulus represented by physical 
activity. Collectively, the stay at high altitude and the 
exercise carried out could suggest a rearrangement 
in SM fibers, rather than a regeneration.
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